Literature DB >> 32838997

Reply to Brandon A. Mahal, Anthony V. D'Amico, and Paul L. Nguyen's Letter to the Editor re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96.

Neal D Shore1, David Dearnaley2, Bertrand Tombal3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32838997     DOI: 10.1016/j.eururo.2020.07.034

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  Therapeutic effects of an oral gonadotropin-releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF.

Authors:  Kazuki Nakao; Keiji Kuroda; Takashi Horikawa; Azusa Moriyama; Hiroyasu Juen; Akiko Itakura; Hideaki Watanabe; Satoru Takamizawa; Yuko Ojiro; Koji Nakagawa; Rikikazu Sugiyama
Journal:  Reprod Med Biol       Date:  2021-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.